Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03729804
Title Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA) ((COBRA))
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Chicago
Indications

multiple myeloma

Therapies

Bortezomib + Dexamethasone + Lenalidomide

Carfilzomib + Dexamethasone + Lenalidomide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.